T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV

Blood. 2000 Dec 1;96(12):3866-71.

Abstract

Cell-mediated immunity and T-lymphocyte maturation are impaired in HIV-infected children. These abnormalities would be detected in HIV-uninfected offspring of HIV women (seroreverters [SR]) if HIV or its soluble proteins could cross the placental barrier. Immunophenotypic analyses were performed in 20 healthy HIV-uninfected newborns of HIV-infected mothers (SR), and in 14 healthy newborns of HIV-negative women (UC). The same analyses were performed in 3 groups of older children: SR (n = 41); UC (n = 15); and HIV-infected children (n = 25). Antigen-specific cells were evaluated with ELISpot and fluorimetric analyses; IL-7 serum concentration was measured by enzyme-linked immunosorbent assay (ELISA). Results showed that in SR newborns: (1) the CD4/CD8 ratio was reduced, (2) CD4(+) and CD8(+) naive T-cell percentages were decreased, (3) percentage of activated CD8(+) T cells was increased, and (4) percentages of CD3(+)/4(-)/8(-) (DN) and DN/25(-)/44(+) were augmented. These abnormalities were partially retained in older SR children. CD4(+) and CD8(+) HIV-specific cells were detected in a portion of newborn SRs but not in older SRs. Serum IL-7 was augmented both in newborn and older SRs. Cell-mediated immunity and T-cell maturation are altered even in HIV-uninfected newborns of HIV-infected mothers; these abnormalities persist over time. The biologic significance of these observations and potential subsequent clinical events should be investigated in larger cohorts of seroreverters. (Blood. 2000;96:3866-3871)

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Antigens, Surface / blood
  • CD4 Antigens / blood
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Differentiation / immunology*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • HIV Envelope Protein gp160 / pharmacology
  • HIV Infections / immunology
  • HIV Infections / transmission*
  • HIV Seropositivity
  • Humans
  • Immunity, Cellular / immunology
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Interferon-gamma / metabolism
  • Interleukin-7 / blood
  • Lymphocyte Activation / drug effects
  • Male
  • Mitogens / pharmacology
  • Mothers
  • T-Lymphocytes / pathology*

Substances

  • Antigens, Surface
  • CD4 Antigens
  • HIV Envelope Protein gp160
  • Interleukin-7
  • Mitogens
  • Interferon-gamma